日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group

儿童肿瘤协作组的一份报告指出,不良组织学特征与临床M期相结合,可定义高危神经母细胞瘤。

Hazard, Florette K; Toland, Angus M S; Tan, Serena Y; Chiu, Bill; Ikegaki, Naohiko; Naranjo, Arlene; Cohn, Susan L; London, Wendy B; Gastier-Foster, Julie M; Ramirez, Nilsa C; Reshmi, Shalini C; Wagner, Elizabeth; Nuchtern, Jed; Asgharzadeh, Shahab; Marachelian, Araz; Maris, John M; Bagatell, Rochelle; Park, Julie R; Irwin, Meredith S; Hogarty, Michael D; Shimada, Hiroyuki

International neuroblastoma risk group consortium: a model of networking for rare cancers

国际神经母细胞瘤风险组联盟:罕见癌症网络模式

Cohn, Susan L; London, Wendy B; Schleiermacher, Gudrun; Moreno, Lucas; Ambros, Inge M; Ambros, Peter F; Bagatell, Rochelle; Popovic, Maja Beck; Beiske, Klaus Hermann; Berthold, Frank; Birz, Suzi; Brisse, Hervé J; Brodeur, Garrett M; Brock, Penelope R; Burchill, Susan; Eggert, Angelika; Federico, Sara M; Fischer, Matthias; Furner, Brian T; Hero, Barbara; Machin, David; Kamijo, Takehiko; Matthay, Katherine K; Nakagawara, Akira; Naranjo, Arlene; Pötschger, Ulrike; Valteau-Couanet, Dominique; Watkins, Michael T; Irwin, Meredith S; Volchenboum, Samuel L; Park, Julie R; Pearson, Andrew D J

Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study

儿童肿瘤协作组研究:高危神经母细胞瘤诊断时克隆和亚克隆驱动基因突变的频率和临床意义

Berko, Esther R; Naranjo, Arlene; Daniels, Alexander A; McNulty, Samantha N; Krytska, Kateryna; Druley, Todd; Zelley, Kirstin; Koneru, Balakrishna; Chen, Lulu; Polkosnik, Grace; Irwin, Meredith S; Bagatell, Rochelle; Maris, John M; Reynolds, C Patrick; DuBois, Steven G; Park, Julie R; Mossé, Yael P

Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531

影像定义风险因素(IDRF)评估在中危神经母细胞瘤患者中的应用:来自儿童肿瘤协作组研究 ANBL0531 的报告

Brown, Erin G; Adkins, E Stanton; Mattei, Peter; Hoffer, Fredric A; Wootton-Gorges, Sandra L; London, Wendy B; Naranjo, Arlene; Schmidt, Mary L; Hogarty, Michael D; Irwin, Meredith S; Cohn, Susan L; Park, Julie R; Maris, John M; Bagatell, Rochelle; Twist, Clare J; Nuchtern, Jed G; Davidoff, Andrew M; Newman, Erika A; Lal, Dave R

Comparative single-cell transcriptomic profiling of patient-derived renal carcinoma cells in cellular and animal models of kidney cancer.

在肾癌细胞和动物模型中,对患者来源的肾癌细胞进行比较单细胞转录组分析

Huang Richard, Kee Lynn, Gont Alexander, Meens Jalna, Ferens Fraser G, Irwin Meredith S, Ailles Laurie, Yuzwa Scott A, Robinson Claire M, Ohh Michael

Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group

儿童肿瘤协作组关于高危神经母细胞瘤早期临床试验入组情况的种族、民族和贫困状况报告

Umaretiya, Puja J; Naranjo, Arlene; Zhang, Fan F; Irwin, Meredith S; DuBois, Steven G; Bagatell, Rochelle; Bona, Kira

Improvements in Children's Oncology Group neuroblastoma risk stratification through a change in age cut-off and use of INRGSS

儿童肿瘤协作组通过改变年龄界限和使用INRGSS改进神经母细胞瘤风险分层。

London, Wendy B; Bousquet, Hannah; Irwin, Meredith S; Hogarty, Michael D; Cohn, Susan L

Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification

儿童肿瘤协作组风险分层中年龄界限从 12 个月调整至 18 个月后,神经母细胞瘤患者接受减少治疗后的生存情况

Bender, Hannah G; Irwin, Meredith S; Hogarty, Michael D; Castleberry, Robert; Maris, John M; Kao, Pei-Chi; Zhang, Fan F; Naranjo, Arlene; Cohn, Susan L; London, Wendy B

The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations

整合基因组学在儿童癌症中的临床应用不仅限于可靶向突变。

Villani, Anita; Davidson, Scott; Kanwar, Nisha; Lo, Winnie W; Li, Yisu; Cohen-Gogo, Sarah; Fuligni, Fabio; Edward, Lisa-Monique; Light, Nicholas; Layeghifard, Mehdi; Harripaul, Ricardo; Waldman, Larissa; Gallinger, Bailey; Comitani, Federico; Brunga, Ledia; Hayes, Reid; Anderson, Nathaniel D; Ramani, Arun K; Yuki, Kyoko E; Blay, Sasha; Johnstone, Brittney; Inglese, Cara; Hammad, Rawan; Goudie, Catherine; Shuen, Andrew; Wasserman, Jonathan D; Venier, Rosemarie E; Eliou, Marianne; Lorenti, Miranda; Ryan, Carol Ann; Braga, Michael; Gloven-Brown, Meagan; Han, Jianan; Montero, Maria; Spatare, Famida; Whitlock, James A; Scherer, Stephen W; Chun, Kathy; Somerville, Martin J; Hawkins, Cynthia; Abdelhaleem, Mohamed; Ramaswamy, Vijay; Somers, Gino R; Kyriakopoulou, Lianna; Hitzler, Johann; Shago, Mary; Morgenstern, Daniel A; Tabori, Uri; Meyn, Stephen; Irwin, Meredith S; Malkin, David; Shlien, Adam

Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

基因组和临床因素对≥18个月龄、组织学预后不良且无MYCN扩增的III期神经母细胞瘤患儿预后的影响:儿童肿瘤协作组(COG)报告

Pinto, Navin; Naranjo, Arlene; Ding, Xiangming; Zhang, Fan F; Hibbitts, Emily; Kennedy, Rebekah; Tibbetts, Rachelle; Wong-Michalak, Shannon; Craig, David W; Manojlovic, Zarko; Hogarty, Michael D; Kreissman, Susan; Bagatell, Rochelle; Irwin, Meredith S; Park, Julie R; Asgharzadeh, Shahab